TRIP
50
-4
KLAC
38
-6
ADBE
47
-9
HCP
56
-8
KHC
9
-4
CSX
57
-4
FFIV
66
-4
HAL
48
-3
UNH
57
-2
ILMN
32
-9
FAST
57
-3
IPG
34
-9
FRT
41
-2
BEN
50
9
TMO
42
-6
ABT
59
2
CRM
60
-7
RRC
52
-6
XEL
67
2
COP
57
-2
TRIP
50
-4
KLAC
38
-6
ADBE
47
-9
HCP
56
-8
KHC
9
-4
CSX
57
-4
FFIV
66
-4
HAL
48
-3
UNH
57
-2
ILMN
32
-9
FAST
57
-3
IPG
34
-9
FRT
41
-2
BEN
50
9
TMO
42
-6
ABT
59
2
CRM
60
-7
RRC
52
-6
XEL
67
2
COP
57
-2
Financhill
Back

Omega Therapeutics Quote, Financials, Valuation and Earnings

"This Changes Everything" - Trump Hands Millions Massive IRS Gift

Learn More Here
Sell
39

OMGA
Omega Therapeutics

Last Price:
0.77
Seasonality Move:
33.78%

7 Day Trial

ALL ACCESS PASS

$ 7

America's enemies are regrouping & it may sucker punch your savings

Click here to learn more.

Omega Therapeutics Price Quote

$0.77
-0.06 (-7.05%)
(Updated: November 18, 2024 at 5:55 PM ET)

Omega Therapeutics Key Stats

Sell
39
Omega Therapeutics (OMGA) is a Sell
Day range:
$0.77 - $1.01
52-week range:
$0.89 - $6.30
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
8.82
P/B ratio:
2.12%
Volume:
1.4M
Avg. volume:
397K
1-year change:
-55.46%
Market cap:
$55.7M
Revenue:
$3.1M
EPS:
$-1.42

How Much Does Omega Therapeutics Make?

Is Omega Therapeutics Growing As A Company?

  • What Is Omega Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 1.81%
  • What Is Omega Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Omega Therapeutics Stock Price Performance

What Is Omega Therapeutics 52-Week High & Low?

Omega Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Omega Therapeutics?

  • How Much Debt Does Omega Therapeutics Have?
    Total long term debt quarterly is $16.9M
  • How Much Cash Does Omega Therapeutics Have?
    Cash and short term investments quarterly total is $45.9M
  • What Is Omega Therapeutics’s Book Value Per Share?
    Book value per share is 0.48

Is Omega Therapeutics Cash Flow Positive?

  • What Is OMGA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$64.6M
  • What Is Omega Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$566K
  • What Is Omega Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $5.5M

Omega Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    OMGA return on invested capital is -100.86%
  • What Is Omega Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -39.33%
  • What Is OMGA Return On Equity?
    ROE is a measure of profitability and is -132.56%

Omega Therapeutics Earnings Date & Stock Price

Omega Therapeutics Competitors

Omega Therapeutics Dividend Yield

Omega Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 16.67%
Revenue: 181.16% 112.55%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 10.57
Upside from Last Price: 1176.13%

Major Shareholders

  • How many OMGA shares are owned by institutional investors?
    66.9M OMGA shares are owned by institutional investors
  • How many OMGA shares are owned by insiders?
    971.7K OMGA shares are owned by insiders